| Literature DB >> 33043456 |
Kyra Yl Chua1, Natasha E Holmes1, Jason Kwong1.
Abstract
Entities:
Keywords: COVID-19; Communicable diseases; Infection control; Infectious diseases; Public health; Respiratory tract infections
Mesh:
Year: 2020 PMID: 33043456 PMCID: PMC7675244 DOI: 10.5694/mja2.50809
Source DB: PubMed Journal: Med J Aust ISSN: 0025-729X Impact factor: 7.738
| Patient number |
Age (years) | Sex |
Duration of symptoms (days) | Number of swabs collected after first positive swab | Days between first PCR positive swab and second negative swab |
|---|---|---|---|---|---|
| 1 | 62 | Male | 10 | 5 | 42 |
| 2 | 20 | Female | 5 | 5 | 34 |
| 3 | 24 | Female | 1 | 5 | 32 |
| 4 | 32 | Female | Patient asymptomatic | 5 | 33 |
| 5 | 56 | Male | 23 | 3 | na |
| 6 | 26 | Female | 8 | 6 | 43 |
| 7 | 62 | Female | 28 | 7 | 53 |
| 8 | 50 | Female | 12 | 2 | 11 |
| 9 | 35 | Female | 11 | 2 | 13 |
| 10 | 52 | Female | 14 | 3 | 21 |
| 11 | 55 | Female | Unable to ascertain | 2 | 23 |
na = not applicable; PCR = polymerase chain reaction.
Of two consecutive negative swabs. † Patient with asthma.
Patient with asthma.
The last collected specimen from patient 5 was PCR positive 11 days after initial positive specimen. The nucleic acid detection assay used was the AusDiagnostics Coronavirus Typing (8‐well) assay. This is a multiplex‐tandem PCR assay that employs two rounds of amplification. The cycle take‐off value for the last positive specimen on patient 5 was 23 cycles in the second round of amplification.
Patient with hypertension.
Patient with rheumatoid arthritis.